Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Anticipate generic drug launch
|Title:||Organis amine phosphonic acid complexes for the treatment of calcific tumors|
|Abstract:||Particle-emitting radionuclides, e.g. Samarium-153, have been complexed with organic aminoalkylenephosphonic acids wherein the nitrogen and phosphorus are interconnected by an alkylene group or substituted alkylene group. These complexes have been found useful in compositions for the therapeutic treatment of calcific tumors in animals.|
|Inventor(s):||Simon; Jaime (Angleton, TX), Wilson; David A. (Richwood, TX), Volkert; Wynn A. (Columbia, MO), Troutner; David E. (Columbia, MO), Goeckeler; William F. (Midland, MI)|
|Assignee:||The Dow Chemical Company (Midland, MI)|
Patent Claim Types:|
see list of patent claims
|Composition; Compound; Formulation; Use; Dosage form;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|African Regional IP Organization (ARIPO)||163||► subscribe|
|African Regional IP Organization (ARIPO)||9000202||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.